Nikhil Puri

Nikhil Puri has had an almost 30-year association with the pharmaceutical industry, in the capacity of an investor, senior executive and investment banker.  He is currently a Partner at Signet Healthcare Partners that invests extensively in the pharma and pharma services sectors and manages the firms’ investments in Curida, Laxai Life Sciences, Leading Pharma, and GBI Biomanufacturing. Previously he led global business development for the Established Pharma business within Pfizer that generated approximately $25 billion in annual revenues across five continents.  Before Pfizer, he spent 15 years on Wall Street as a senior investment banker covering the pharma sector and was involved in M&A and capital markets transactions that exceeded $40 billion in value.